Cullinan Therapeutics, Inc. (CGEM)
(Real Time Quote from BATS)
$26.74 USD
+0.36 (1.37%)
Updated May 15, 2024 03:30 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/16/24 |
---|---|
Current Quarter | -0.90 |
EPS Last Quarter | -0.54 |
Last EPS Surprise | 43.75% |
ABR | 1.00 |
Earnings ESP
|
1.15% |
---|---|
Current Year | -3.23 |
Next Year | -3.14 |
EPS (TTM) | -3.69 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 15.00M | 50.68M |
# of Estimates | NA | NA | 1 | 2 |
High Estimate | NA | NA | 15.00M | 53.64M |
Low Estimate | NA | NA | 15.00M | 47.71M |
Year ago Sales | 0.00M | 0.00M | NA | 15.00M |
Year over Year Growth Est. | NA | NA | NA | 237.83% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.90 | -0.79 | -3.23 | -3.14 |
# of Estimates | 7 | 6 | 7 | 7 |
Most Recent Consensus | -0.72 | -0.73 | -3.02 | -2.76 |
High Estimate | -0.72 | -0.67 | -2.87 | -2.35 |
Low Estimate | -1.02 | -1.01 | -3.80 | -4.14 |
Year ago EPS | -1.42 | -0.82 | -3.69 | -3.23 |
Year over Year Growth Est. | 36.62% | 3.66% | 12.47% | 2.74% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 3 | 3 | 2 |
Up Last 60 Days | 1 | 3 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 1 |
Down Last 60 Days | 1 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.90 | -0.79 | -3.23 | -3.14 |
7 Days Ago | -0.90 | -0.79 | -3.23 | -3.14 |
30 Days Ago | -0.92 | -0.87 | -3.55 | -3.37 |
60 Days Ago | -0.92 | -0.87 | -3.55 | -3.37 |
90 Days Ago | -0.98 | -0.88 | -3.84 | -3.71 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.89 | -0.78 | -3.11 | -2.98 |
Zacks Consensus Estimate | -0.90 | -0.79 | -3.23 | -3.14 |
Earnings ESP | 1.15% | 0.89% | 3.46% | 5.01% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.54 | -0.91 | -0.82 | -1.42 | NA |
Estimate | -0.96 | -0.91 | -0.99 | -0.84 | NA |
Difference | 0.42 | 0.00 | 0.17 | -0.58 | 0.00 |
Surprise | 43.75% | 0.00% | 17.17% | -69.05% | -2.03% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more